Last updated: 22 July 2019 at 8:57am EST

Allen Andersson Net Worth




The estimated Net Worth of Allen Andersson is at least $15.6 Million dollars as of 7 May 2009. Allen Andersson owns over 287,975 units of Corcept Therapeutics Inc stock worth over $7,454,622 and over the last 17 years Allen sold CORT stock worth over $8,157,111.

Allen Andersson CORT stock SEC Form 4 insiders trading

Allen has made over 19 trades of the Corcept Therapeutics Inc stock since 2007, according to the Form 4 filled with the SEC. Most recently Allen sold 287,975 units of CORT stock worth $201,583 on 7 May 2009.

The largest trade Allen's ever made was selling 10,914,507 units of Corcept Therapeutics Inc stock on 6 February 2009 worth over $7,531,010. On average, Allen trades about 720,678 units every 27 days since 2007. As of 7 May 2009 Allen still owns at least 209,694 units of Corcept Therapeutics Inc stock.

You can see the complete history of Allen Andersson stock trades at the bottom of the page.



What's Allen Andersson's mailing address?

Allen's mailing address filed with the SEC is 1875 K STREET, N.W., SUITE 700, WASHINGTON, DC, 20006.

Insiders trading at Corcept Therapeutics Inc

Over the last 21 years, insiders at Corcept Therapeutics Inc have traded over $107,318,493 worth of Corcept Therapeutics Inc stock and bought 71,912,273 units worth $127,133,071 . The most active insiders traders include Patrick G Enright, Allen Andersson, and Ventures, Llc Paperboy. On average, Corcept Therapeutics Inc executives and independent directors trade stock every 14 days with the average trade being worth of $8,010,233. The most recent stock trade was executed by William Guyer on 3 September 2024, trading 10,000 units of CORT stock currently worth $216,500.



What does Corcept Therapeutics Inc do?

leading the field in the discovery of drugs that modulate the effects of cortisol the adverse effects of excess cortisol have been corcept’s focus since the company’s inception. abnormal levels and release of cortisol play a role in a variety of metabolic, oncological, and psychiatric diseases, and we are currently studying a new generation of compounds that may mitigate the effects of excess cortisol. in addition to our work with mifepristone, we have developed over 300 proprietary molecules, advancing the most promising of these to the clinic to see if they can mitigate the effects of excess cortisol and the serious, sometimes life-threatening conditions that may result. all of these compounds competitively block the glucocorticoid receptor (gr), but not the progesterone receptor. scientific literature suggests that competitive gr antagonism may have a role in treating many conditions, including post-traumatic stress disorder, mild cognitive impairment, alzheimer’s disease, alcoholis



What does Corcept Therapeutics Inc's logo look like?

Corcept Therapeutics Inc logo

Complete history of Allen Andersson stock trades at Corcept Therapeutics Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
7 May 2009 Allen Andersson
Director
Sale 287,975 $0.70 $201,583
7 May 2009
209,694
1 May 2009 Allen Andersson
Director
Sale 209,655 $0.69 $144,662
1 May 2009
497,669
14 Apr 2009 Allen Andersson
Director
Sale 137,857 $1.00 $137,857
14 Apr 2009
707,324
18 Feb 2009 Allen Andersson
Director
Sale 202,857 $0.70 $142,000
18 Feb 2009
1,142,324
6 Feb 2009 Allen Andersson
Director
Sale 10,914,507 $0.69 $7,531,010
6 Feb 2009
845,181
25 Mar 2008 Allen Andersson
Director
Buy 2,118,270 $2.77 $5,867,608
25 Mar 2008
10,965,270
5 Feb 2008 Allen Andersson
Director
Buy 32,000 $2.74 $87,680
5 Feb 2008
8,847,000
29 Jan 2008 Allen Andersson
Director
Buy 12,500 $2.72 $34,000
29 Jan 2008
8,815,000
16 Jan 2008 Allen Andersson
Director
Buy 37,500 $2.61 $97,875
16 Jan 2008
8,802,500
9 Jan 2008 Allen Andersson
Director
Buy 15,000 $2.77 $41,550
9 Jan 2008
8,765,000
21 Dec 2007 Allen Andersson
Director
Buy 45,000 $3.01 $135,450
21 Dec 2007
8,750,000
10 Dec 2007 Allen Andersson
Director
Buy 45,000 $2.89 $130,050
10 Dec 2007
8,705,000
26 Nov 2007 Allen Andersson
Director
Buy 100,617 $3.01 $302,857
26 Nov 2007
8,660,000
15 Nov 2007 Allen Andersson
Director
Buy 104,000 $2.91 $302,640
15 Nov 2007
8,559,383
13 Nov 2007 Allen Andersson
Director
Buy 110,000 $2.87 $315,700
13 Nov 2007
8,455,383
12 Nov 2007 Allen Andersson
Director
Buy 20,000 $2.75 $55,000
12 Nov 2007
8,345,383
8 Nov 2007 Allen Andersson
Director
Buy 40,000 $2.76 $110,400
8 Nov 2007
8,325,383
24 Sep 2007 Allen Andersson
Director
Buy 1,190,476 $2.10 $2,500,000
24 Sep 2007
8,285,383
17 Aug 2007 Allen Andersson
Director
Buy 952,380 $2.10 $1,999,998
17 Aug 2007
7,094,907


Corcept Therapeutics Inc executives and stock owners

Corcept Therapeutics Inc executives and other stock owners filed with the SEC include: